免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

NCT:NCT07548164 · RECRUITING

NCT编号NCT07548164
状态RECRUITING
开始日期2026-04-16
完成时间2029-04-16
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated

简要摘要

In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑